Hepatitis E is a cause of unexplained hepatitis in The Netherlands

被引:47
作者
Waar, K
Herremans, MMPT
Vennema, H
Koopmans, MPG
Benne, CA
机构
[1] Univ Groningen, Univ Groningen Hosp, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands
[2] Natl Inst Publ Hlth & Environm, Diagnost Lab Infect Dis, Div Virol, NL-3720 BA Bilthoven, Netherlands
[3] Publ Hlth Lab Groningen & Drenthe, Groningen, Netherlands
关键词
acute hepatitis; hepatitis E virus; hepatitis E;
D O I
10.1016/j.jcv.2004.10.015
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Hepatitis E virus (HEV) is the major etiologic agent of enterically transmitted viral hepatitis in much of the developing world. Evidence provided in recent years shows that HEV is also prevalent in very low numbers in non-endemic countries. Recently, a cluster of three patients with acute hepatitis E but no history of travel to endemic countries was discovered in the geographical area provided with service by the Public Health Laboratory Groningen and Drenthe, The Netherlands. Objective: This lead to the question whether hepatitis E is a cause of unexplained hepatitis in this district. Study design: The prevalence of anti-HEV IgG and IgM among 209 patients with clinical signs of hepatitis, negative test for hepatitis A-C, no history of foreign travel and no other cause of hepatocellular damage was compared with a matched control group of 209 individuals. Results: We found a significant difference in seroprevalence between the two groups for IgG anti-HEV as determined with the Abbot HEV ETA (6.2% versus 0.5%); however this difference could not be confirmed with the Genelabs Diagnostics HEV IgG ELISA (6.7% versus 3.8%). For confirmed cases of IgM anti-HEV we also detected a significant difference between the two groups (3.3% versus 0.5%). Remarkably, the combination of IgG and IgM anti-HEV was only found among hepatitis patients. Conclusion: This study provides evidence of locally acquired hepatitis E in The Netherlands. Therefore, in cases of unexplained acute hepatitis. the diagnosis of hepatitis E should be considered even in the absence of foreign travel. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 24 条
[1]  
Aggarwal R, 1997, Trop Gastroenterol, V18, P49
[2]   Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis [J].
Berke, T ;
Matson, DO .
ARCHIVES OF VIROLOGY, 2000, 145 (07) :1421-1436
[3]   Sporadic cases of acute autochthonous hepatitis E in Spain [J].
Buti, M ;
Clemente-Casares, P ;
Jardi, R ;
Formiga-Cruz, M ;
Schaper, M ;
Valdes, A ;
Rodriguez-Frias, F ;
Esteban, R ;
Girones, R .
JOURNAL OF HEPATOLOGY, 2004, 41 (01) :126-131
[4]  
Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448
[5]   Hepatitis E virus antibody prevalence among persons who work with swine [J].
Drobeniuc, J ;
Favorov, MO ;
Shapiro, CN ;
Bell, BP ;
Mast, EE ;
Dadu, A ;
Culver, D ;
Iarovoi, P ;
Robertson, BH ;
Margolis, HS .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (12) :1594-1597
[6]   Hepatitis E [J].
Krawczynski, K ;
Aggarwal, R ;
Kamili, S .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2000, 14 (03) :669-+
[7]   Acute hepatitis E by a new isolate acquired in the United States [J].
Kwo, PY ;
Schlauder, GG ;
Carpenter, HA ;
Murphy, PJ ;
Rosenblatt, JE ;
Dawson, GJ ;
Mast, EE ;
Krawczynski, K ;
Balan, V .
MAYO CLINIC PROCEEDINGS, 1997, 72 (12) :1133-1136
[8]   Evaluation of assays for antibody to hepatitis E virus by a serum panel [J].
Mast, EE ;
Alter, MJ ;
Holland, PV .
HEPATOLOGY, 1998, 27 (03) :857-861
[9]   Sporadic acute hepatitis E in the United Kingdom: an underdiagnosed phenomenon? [J].
McCrudden, R ;
O'Connell, S ;
Farrant, T ;
Beaton, S ;
Iredale, JP ;
Fine, D .
GUT, 2000, 46 (05) :732-733
[10]   Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries [J].
Meng, XJ ;
Wiseman, B ;
Elvinger, F ;
Guenette, DK ;
Toth, TE ;
Engle, RE ;
Emerson, SU ;
Purcell, RH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (01) :117-122